Quantcast

Latest Dopamine antagonists Stories

2014-02-12 20:22:04

LOS ALTOS, Calif., Feb. 12, 2014 /PRNewswire/ -- Altos Therapeutics, LLC, was recently informed by the United States Patent and Trademark Office that its pending patent application covering Altos' dopamine D2/D3 receptor antagonists for treating gastrointestinal diseases will be granted. The patent that issues will broadly and specifically cover the company's drug candidates, their pharmaceutical compositions, and their use for treating a number of important gastrointestinal...

2011-06-20 06:00:00

WASHINGTON, June 20, 2011 /PRNewswire/ -- The U.S. Supreme Court is expected to rule shortly on whether generic drug companies must adequately warn doctors about new or revised risks to patients who have taken the drugs they make. (Pliva v Mensing No. 09-993, Actavis v Mensing No.08-3850 and Actavis v Demahy No. 09-1501) All three cases involve patients who took metoclopramide, the generic version of the brand-name drug Reglan. An estimated 10,000 Reglan-metoclopramide lawsuits would...

2010-05-03 11:59:00

Reglan, metoclopramide never approved for use in infants HOUSTON, May 3 /PRNewswire-USNewswire/ -- Recently, researchers have observed a disturbing trend in neonatal units across the country: doctors prescribing Reglan -- also known by its generic name, metoclopramide -- to treat premature infants. This alarming development has raised serious concerns from many consumer safety advocates, particularly because the drug was never approved for use in infants. Reglan (metoclopramide) was...

2009-09-09 07:00:00

WILMINGTON, N.C., Sept. 9 /PRNewswire/ -- Wilmington Pharmaceuticals announced today the U.S. Food and Drug Administration (FDA) has granted marketing approval for METOZOLV((TM)) ODT (metoclopramide HCl), an orally disintegrating formulation of metoclopramide for the treatment of gastroesophageal reflux disease (GERD) and diabetic gastroparesis. Wilmington has licensed METOZOLV ODT to Salix Pharmaceuticals, Inc., a specialty pharmaceutical company with a focus on gastrointestinal...

444b1d21359392b42f89fdabcceedef71
2009-06-11 10:40:00

Researchers in Israel have shown that the anti-nausea drug metoclopramide does no obvious harm to the fetus in pregnant women. This discovery may lead more doctors to prescribe the drug for those women suffering from morning sickness, The Associated Press reported. As of now, there are no approved drugs in the U.S. for morning sickness, which many women experience during the first three months of pregnancy "” even all day for some. Up to 80 percent of pregnant women have at least one...

2009-05-06 10:28:47

Collaborative Canada-France study published in European Journal of Obstetrics and Gynecology and Reproductive Biology Nausea and vomiting are telltale indicators of pregnancy, affecting more than 80 percent of future mothers. For a few moms-to-be, symptoms can become so severe that hospitalization is required. Yet a new medication protocol, introduced by the Sainte-Justine University Hospital Center, appears effective in improving symptoms more quickly and provides a safer option than those...

2009-05-05 08:05:00

SAN DIEGO, May 5 /PRNewswire/ -- - Evoke Pharma, Inc., a privately-held specialty pharmaceutical company, announced today that it has initiated a Phase 2b clinical trial to evaluate EVK-001 for the treatment of adults with symptoms of diabetic gastroparesis. Gastroparesis is a syndrome characterized by delayed emptying of the stomach into the intestine following a meal in the absence of mechanical obstruction. Diabetes is an important cause of gastroparesis, but other identified causes...

370572c9a414d9bd74461f1845d6423a1
2009-02-27 11:12:08

The US Food and Drug Administration is requiring makers of the heartburn drug Reglan to add a "black box" warning to inform patients that long term or high doses of the drug have been linked to involuntary movement throughout the body. More than 2 million Americans use the drugs to treat gastroesophageal reflux disease and other stomach problems, said the FDA. However, they warn that chronic use can cause tardive dyskinesia "“ characterized by uncontrollable repetitive movements of the...

2009-02-26 14:42:32

The U.S. Food and Drug Administration is ordering manufacturers of the drug metoclopramide to add a boxed warning about the drug's side effects. The FDA said the drug, used to treat gastrointestinal disorders, is sold as tablets, syrups and injections as Reglan Tablets, Reglan Oral Disintegrating Tablets, Metoclopramide Oral Solution and Reglan Injection. The federal agency said more than two million U.S. residents use the products. FDA officials said the boxed warning must be added to the...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.